TrialPharmacoEconomics2011

Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing chemotherapy: a NICE single technology appraisal.

Rumona Dickson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.